Safety of anti-immunoglobulin E therapy with omalizumab in allergic patients at risk of geohelminth infection

BACKGROUND: Although the role of immunoglobulin E (IgE) in immunity against helminth parasites is unclear, there is concern that therapeutic antibodies that neutralize IgE (anti-IgE) may be unsafe in subjects at risk of helminth infection. OBJECTIVE: We conducted an exploratory study to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Cruz, A A, Lima, F, Sarinho, E, Ayre, G, Martin, C, Fox, H, Cooper, P J
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2007
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1859973/
https://www.ncbi.nlm.nih.gov/pubmed/17250692
http://dx.doi.org/10.1111/j.1365-2222.2007.02650.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1859973/
https://www.ncbi.nlm.nih.gov/pubmed/17250692
http://dx.doi.org/10.1111/j.1365-2222.2007.02650.x

Ejemplares similares